Table 7.
Global Prevalence and Mortality of Cardiomyopathy and Myocarditis by Sex, 202079
| Deaths (95% Ul) | Prevalence (95% Ul) | Deaths (95% Ul) | Prevalence (95% Ul) | Deaths (95% Ul) | Prevalence (95% Ul) | |
|---|---|---|---|---|---|---|
| Total number (millions), 2020 | 0.37 (0.33 to 0.41) | 6.11 (5.02 to 7.22) | 0.23 (0.20 to 0.25) | 3.41 (2.81 to 4.04) | 0.14 (0.12 to 0.17) | 2.70 (2.23 to 3.22) |
| Percent change in total number, 1990–2020 | 43.01 (29.79 to 55.73) | 59.95 (53.96 to 66.69) | 57.86 (42.26 to 74.64) | 61.68 (55.04 to 68.81) | 24.56 (10.88 to 37.41) | 57.81 (51.84 to 64.72) |
| Percent change in total number, 2010–2020 | −0.95 (−6.03 to 4.03) | 18.24 (15.58 to 21.14) | −1.07 (−7.37 to 5.36) | 17.23 (14.36 to 20.43) | −0.76 (−6.61 to 5.54) | 19.54 (16.56 to 22.98) |
| Rate per 100,000, age standardized, 2020 | 4.69 (4.15 to 5.11) | 76.92 (63.29 to 91.56) | 6.20 (5.53 to 6.85) | 88.75 (73.37 to 104.96) | 3.32 (2.73 to 3.81) | 65.88 (54.01 to 78.66) |
| Percent change in rate, age standardized 1990–2020 | −37.21 (−42.14 to −32.33) | −7.07 (−11.11 to −3.50) | −31.01 (−36.65 to −24.75) | −6.25 (−10.08 to −2.95) | −45.57 (−51.30 to −40.75) | −7.90 (−12.50 to −3.75) |
| Percent change (%) in rate, age standardized 2010–2020 | −23.86 (−27.57 to −20.17) | −1.40 (−3.11 to 0.19) | −22.81 (−27.35 to −18.16) | −2.48 (−4.45 to 0.71) | −25.15 (−29.40 to −20.44) | −0.08 (−2.33 to 1.96) |
During each annual GBD Study cycle, population health estimates are produced for the full time series. Improvements in statistical and geospatial modeling methods and the addition of new data sources may lead to changes in past results across GBD Study cycles. GBD= Global Burden of Disease Study; UI = uncertainty interval.
79.
Institute for Health Metrics and Evaluation. Global Burden of Disease Study. 2020 [cited 2023 Jul 9], Cardiomyopathy and myocarditis – Level 3 cause. Available from: https://www.healthdata.org/results/gbd_summaries/2019/cardiomyopathy-and-myocarditis-level-3-cause